The latest release of the IUPHAR/BPS Guide to Pharmacology database was made on 26th April 2023. This database release is version 2023.1, and is the first release this year. The following blog post gives details of the key content updates…
Blog Archives
Exploiting the Guide to Pharmacology substance (SID) tags in PubChem
This post on SID tagging has been reproduced, with permission, from Dr. Chris Southan’s original post in his blog – Bio <-> Chem. It is intended to be user-orientated, those interested in the technicalities are welcome to contact the Guide…
GtoPdb NAR database issue 2018: Journal to database connectivity and journal to GtoPdb links
The following blog post acts as supplementary data to the 2018 NAR Database Issue Journal to Database connectivity The citation provenance of all entity records and contextual comments selected by the curators and NC-IUPHAR members in GtoPdb is supported by…
Posted in Chemical curation
GtoPdb NAR database issue 2018: PubChem Content
The following blog post acts as supplementary data to the 2018 NAR Database Issue GtoPdb PubChem Content The GtoPdb PubChem integration strategy has been previously outlined (1). Since 2015 we have made nine PubChem submissions for new releases of our…
Posted in Chemical curation, Publications
A Pharmacologists’ Guide to Resolving Chemical Structures and their Protein Targets from the Literature
This is an introduction to resolving bioactive ligands and their protein targets from the literature. It includes their conversion to standardised molecular identifiers so these can be communicated to the Guide to PHARMACOLOGY (GtoPdb) team. (n.b. identifying what is already…
Case studies in chemical curation III: complexes and component mixtures
The issue of specified mixtures that include pharmacologically active chemical structures is complex and curatorially challenging, as described by this presentation on the topic. This post will briefly cover our handing of salts. A substance in an approved drug preparation may…
Posted in Chemical curation
Case study in chemical curation II: Racemates and how to represent them
Where the drug is a racemate, should we go ‘flat’? Example: ketoconazole Many drugs are racemates, as indicated by their INN document or FDA label. This presents us with a curatorial decision: should we represent both of the enantiomers as…
Posted in Chemical curation
Will the real drugs please stand up? Case studies in chemical curation I
Our database now contains over 6500 ligands, spanning 7 chemical classes. An important part of our curation work is to ensure the chemical structures of these ligands are accurate through both careful curation of new ligands and the running of…
Posted in Chemical curation
guidetopharmacology blog 